Since the cultural diversity in Western Europe is growing, this study assessed whether foreign-born chronic hepatitis B (CHB) patients have more cirrhosis than Dutch-or Belgian-born patients, with a main focus on the Turkish population. Baseline were foreign-born and 59 were Dutch-or Belgian-born. Compared with Dutch-or Belgian-born patients, foreign-born patients had a higher prevalence of low SES (58% vs 31%; P = 0.001) and cirrhosis (27% vs 10%; P = 0.007). Among the Turkish population, there were no significant differences regarding the prevalence of low SES (73% vs 61%; P = 0.170), alcohol abuse (1% vs 5%; P = 0.120), anti-hepatitis C virus positivity (4% vs 0%; P = 0.344), anti-hepatitis D virus positivity (1% vs 6%; P = 0.297), and cirrhosis (37% vs 27%; P = 0.262) between patients (n = 102) living in Turkey (local) and Turkish CHB (n = 38) patients living in the Netherlands or Belgium (immigrant). In multivariate analysis, low SES (odds ratio, 5.7; 95% confidence interval, 2.3-14.5; P < 0.001) was associated with cirrhosis. In this study, foreign-born CHB patients were associated with more advanced HBV-related liver disease with 27% having cirrhosis. However, ethnicity was not associated with cirrhosis when SES was included in the multivariate analysis. The similar prevalence of cirrhosis in local Turkish compared to immigrant Turkish CHB patients is novel and warrants further investigation. wileyonlinelibrary.com/journal/jmv | 623
| INTRODUCTION

Hepatitis B virus (HBV) infection is one of the major infectious diseases
with an estimated two billion people infected with HBV worldwide and more than 240 million chronically infected in the year 2016.
1, 2 An estimated 15% to 40% of those with prolonged HBV infection will develop cirrhosis, liver failure, hepatocellular carcinoma (HCC), or early death. 2, 3 According to the Global Burden of Disease study in 2013, HBV is responsible for up to 700 000 deaths annually, making it together with hepatitis C virus (HCV) infection the seventh leading cause of mortality globally. 4 Progression of chronic hepatitis B (CHB) to cirrhosis and HCC is determined by host-related factors like sex, as well as by viral and other factors (eg, alcohol use). 3, 5, 6 However, a factor that has had less attention in scientific research is the influence of ethnicity on disease outcome.
Furthermore, for HCV, ethnicity is an essential predictor of disease outcome. For instance, more advanced hepatic fibrosis in Hispanics compared to non-Hispanic whites was related to older age and higher occurrence of hepatic steatosis. 7 In addition, studies determining the natural history of HCV have observed less cirrhosis in African Americans when compared with other groups. 8 However, in contrast to HCV, there is little known about the influence of ethnicity on the outcome of HBV infection.
The impact of migration in the European Union (EU) is striking as a high proportion of newly diagnosed CHB infections are considered to have been acquired outside the EU. Migration to the EU occurs mainly from countries with high prevalence of viral hepatitis B. 9 Therefore this study was designed to assess whether foreign-born CHB patients have more advanced fibrotic liver disease than Dutchor Belgian-born patients, with a main focus on the Turkish population that is disproportionately affected by HBV and is a key risk group for CHB in different EU countries. 
| Statistical analysis
Anonymous data collection and analyses were performed using SPSS The baseline characteristics of the foreign-born group and Dutch-or Belgian-born group are presented in Table 1 . The percentage of CHB patients with a low SES (58% vs 31%; P < 0.001) and an infected family member (47% vs 29%; P = 0.011) was higher in foreign-born patients compared with the Dutch-or Belgian-born group. However, in comparison to CHB patients born in the Netherlands or Belgium, there was a lower percentage of foreign-born patients with IDU (3% vs 10%; P = 0.027), MSM (1% vs 15%; P < 0.001), and alcohol abuse (3% vs 12%; P = 0.017).
Among the Turkish population, the percentage of CHB patients with a low SES (73% vs 61%; P = 0.170) and alcohol abuse (1% vs 5%; P = 0.120) was not different between local Turkish CHB patients and immigrant Turkish CHB patients. With regard to risk factors, there was no difference in the number of infected family members (46% vs 53%; P = 0.490).
| Biological characteristics of the study population
When the patients were categorized according to the country of birth, a lower anti-human immunodeficiency virus positivity (3% vs 13%; P = 0.014) was seen in foreign-born group compared to Dutch-or Belgian-born group (Table 2) . Among the Turkish population, there were no significant differences regarding anti-HCV positivity (4% vs 0%; P = 0.344), anti-HIV positivity (0% vs 0%), anti-HDV positivity (1% vs 6%; P = 0.297), and HBeAg positivity (13% vs 26%; P = 0.052) between local Turkish CHB patients and immigrant CHB patients.
| HBV disease outcome
The HBV disease outcome in the ethnic groups is shown in Table 3 .
The foreign-born group had a significantly higher mean METAVIR fibrosis stage (1.9 ± 0.1) than the Dutch-or Belgian-born group (1.2 ± 0.2), P = 0.003. The prevalence of cirrhosis was 27% (foreignborn) and 10% (Dutch-or Belgian-born), P = 0.007. There was a trend of a higher prevalence of hepatic decompensation (P = 0.175) and HCC (P = 0.027) in the foreign-born group. A forward stepwise multiple logistic regression analysis of cirrhosis was then performed including all variables that had a P < 0.20 on univariate analysis (Table 4 ). The following variables were identified to be independent predictors of cirrhosis: low SES (odds ratio
P < 0.001) and baseline bilirubin levels (OR, 1.1; 95% CI, 1.0-1.1; P = 0.001).
| DISCUSSION
The impact of migration to Western Europe is striking as migrants have become the majority of CHB patients in low endemic countries, such as the Netherlands and Belgium. 21 The Turkish migrant population, one of the largest migrant groups in Western Europe, is also disproportionately affected by HBV and is a key risk group for CHB infections in different Western European countries.
As ethnicity is an essential predictor of disease outcome in some diseases, this study assessed whether foreign-born CHB patients have more advanced fibrotic liver disease than Dutch-or Belgian-born patients. The CHB populations in three hospitals, one in the Netherlands, one in Belgium, and one in Turkey, were chosen because it afforded us a chance to study the differences between local Turkish CHB patients and immigrant Turkish CHB patients in a subanalysis.
The most significant finding was that SES appeared to be more important than ethnicity in influencing disease outcome in CHB patients. Compared with Dutch-or Belgian-born patients, the foreign-born CHB patients were associated with more advanced HBV-related liver disease with 27% having cirrhosis. There was also a trend of higher prevalence of hepatic decompensation and HCC in the foreign-born group. However, ethnicity was not associated with cirrhosis when SES was included in the multivariate analysis.
Although we are not aware of any other study that has examined the effect of ethnicity on disease outcome in CHB patients, there is evidence of greater HCV disease progression among Hispanics compared with non-Hispanic whites. 7 In addition, several studies have observed less HCV-associated cirrhosis in African Americans than other ethnic groups.
8,22
T A B L E 1 In line with our findings, the study by Haworth et al 28 reported excess mortality from cirrhosis and HCC among first generation migrants in England and Wales. Moreover, different studies showed a higher incidence of HCC in the Asian immigrant population. [24] [25] [26] Hypothesized explanation for the difference in liver disease outcome in the migrant population included earlier viral infection. In our study, we found a higher prevalence of infected family member as risk factor in the foreign-born group. On the contrary, MSM and IDU as risk factors were more prevalent in the Dutch-or Belgian-born group. These In areas with low HBV endemicity, such as the Netherlands and Belgium, IDU and unprotected sexual intercourse in adults are the main routes of transmission, whereas in areas with high HBV endemicity, perinatal transmission is the predominant route. [29] [30] [31] Childhood horizontal transmission is accepted as the most common route in in intermediate HBV endemic areas, such as Turkey. 32 It has furthermore been accepted that horizontal transmission in early childhood may correlate with poor socioeconomic and hygienic conditions. 33, 34 In a subanalysis among the Turkish population, there was no There are some limitations to the present study. First, this study has some selection bias toward the CHB population; those cured and deceased have not been included in this study, and there is also a possibility that there are CHB patients that have not yet visited the hepatology outpatient department. Second, the data must be interpreted carefully due to the small sample size of the study. Third, even though the patients' income and highest education was recorded upon informed consent, the study by Karlson et al 23 explained the variability in conclusions of previous studies on the role of SES due to the fact that the income is an unstable measure of SES. However, in that study, 83%
of the patients reported no change in income over the 42-month interval. Thus, we believe that changes in income status probably were not an important factor in our study. Fourth, participants may not have been 100% truthful with their answers to the questionnaires due to social desirability bias. Fifth, we cannot exclude the possibility that factors not included in this study might have a role in the examined further incorporated in the current analysis.
In conclusion, these data suggest that SES and not ethnicity is likely Secondly to get an idea of the disease perception and perception of the received care and treatment of CHB patients to improve treatment and thus increase survival rates and quality of life.
